Issue of Shares
Summary by AI BETAClose X
NEWS RELEASE | 7 August 2026
ISSUE OF SHARES
GreenX Metals Limited (GreenX or Company) advises that further to its announcement made on 4 August 2026, the Company has today issued 283,954 ordinary fully paid shares (Shares) in relation to the grant of an additional exploration licence at the Eleonore North Project.
An application will be made for the admission of 283,954 Shares to the Equity shares (international commercial companies secondary listing) listing segment of the Official List of the FCA (Official List) and to trading on the main market of the London Stock Exchange for listed securities (LSE Admission). Timing on LSE Admission will be disclosed once the application has been submitted.
For the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules (DTRs), following LSE Admission, the Company's issued ordinary share capital will be 312,256,505 ordinary shares. The above figure of 312,256,505 may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company following LSE Admission.
GreenX has the following securities on issue:
· 312,256,505 ordinary fully paid shares;
· 11,000,000 performance rights that have an expiry date 8 October 2026;
· 4,025,000 unlisted options exercisable at A$0.55 each on or before 30 November 2026;
· 7,600,000 unlisted options exercisable at A$1.05 each on or before 31 May 2029;
· 7,600,000 unlisted options exercisable at A$1.20 each on or before 31 May 2030; and
· 7,700,000 unlisted options exercisable at A$1.50 each on or before 31 May 2031.
Enquiries:
|
Ben Stoikovich Chief Executive Officer
+44 207 478 3900 ir@greenxmetals.com
|
Kazimierz Chojna Investor Relations - Poland
Kim Eckhof Investor Relations - UK / Germany |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 9 hours ago Johnson Matthey
- 10 hours ago Galliford Try
- 10 hours ago Galliford Try
- 10 hours ago Centrica
- 11 hours ago Smith & Nephew